Published in Dtsch Med Wochenschr on July 23, 1971
Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest (1993) 5.06
Reduced incretin effect in type 2 (non-insulin-dependent) diabetes. Diabetologia (1986) 4.54
Early ERCP and papillotomy compared with conservative treatment for acute biliary pancreatitis. The German Study Group on Acute Biliary Pancreatitis. N Engl J Med (1997) 4.18
Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis. Gastroenterology (1993) 3.98
Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients. Diabetologia (1993) 3.63
Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses. J Clin Endocrinol Metab (1986) 2.80
The incretin concept today. Diabetologia (1979) 2.18
Histopathological classification of nonantral gastric endocrine growths in man. Digestion (1988) 1.85
[Arteriovenous haemofiltration: a new and simple method for treatment of over-hydrated patients resistant to diuretics]. Klin Wochenschr (1977) 1.73
Effect of the somatostatin analogue sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men. Digestion (1987) 1.73
Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis. Scand J Gastroenterol (1989) 1.72
Natural course in chronic pancreatitis. Pain, exocrine and endocrine pancreatic insufficiency and prognosis of the disease. Digestion (1993) 1.71
Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients. J Clin Endocrinol Metab (1996) 1.70
Glucagon-like peptide-1 but not glucagon-like peptide-2 stimulates insulin release from isolated rat pancreatic islets. Diabetologia (1985) 1.67
Influence of feeding and sham feeding upon serum gastrin and gastric acid secretion in control subjects and duodenal ulcer patients. Scand J Gastroenterol (1974) 1.63
Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations. J Clin Endocrinol Metab (1993) 1.61
Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours. Gut (1996) 1.53
Gastrin and G-cells in the antral mucosa of patients with pernicious anaemia, acromegaly and hyperparathyroidism and in a Zollinger-Ellison tumour of the pancreas. Eur J Clin Invest (1971) 1.52
Comparison of the antihypertensive efficiency of nitrendipine, metoprolol, mepindolol and enalapril using ambulatory 24-hour blood pressure monitoring. Am J Cardiol (1990) 1.44
Experimental non-A, non-B hepatitis: four types of cytoplasmic alteration in hepatocytes of infected chimpanzees. Virchows Arch B Cell Pathol Incl Mol Pathol (1980) 1.43
Mucosal gastrin concentration, molecular forms of gastrin, number and ultrastructure of G-cells in patients with duodenal ulcer. Gut (1976) 1.42
Expression of a novel member of the TGF-beta superfamily, growth/differentiation factor-15/macrophage-inhibiting cytokine-1 (GDF-15/MIC-1) in adult rat tissues. Cell Tissue Res (1999) 1.37
Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7-36 amide]) in patients with NIDDM. Diabetologia (1996) 1.37
Therapy with omeprazole in patients with peptic ulcerations resistant to extended high-dose ranitidine treatment. Digestion (1988) 1.34
Aetiology and pathogenesis of pancreatitis. (Current concepts). Scand J Gastroenterol Suppl (1970) 1.29
Gastrointestinal peptides and insulin secretion. Diabetes Metab Rev (1987) 1.27
The influence of glucagon on acute experimental pancreatitis in the rat. Scand J Gastroenterol (1974) 1.26
Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation? Diabetologia (1984) 1.23
Lipodystrophy of the extremities. A dominantly inherited syndrome associated with lipatrophic diabetes. Humangenetik (1975) 1.22
Hypoglycaemia. 1. Insulin secreting tumours. Clin Endocrinol Metab (1976) 1.22
Management of anuric intensive-care patients with arteriovenous hemofiltration. Int J Artif Organs (1980) 1.21
Liver diseases and diabetes mellitus. Prog Liver Dis (1970) 1.21
Sinus histiocytosis with massive lymphadenopathy: evidence for its relationship to macrophages and for a cytokine-related disorder. Histopathology (1999) 1.20
Pathomorphologic, biochemical, and diagnostic aspects of gastrinomas (Zollinger-Ellison syndrome). Hum Pathol (1975) 1.20
Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8. J Clin Endocrinol Metab (1989) 1.17
New developments in the incretin concept. Diabetologia (1985) 1.15
Myo-, neuro-, gastrointestinal encephalopathy (MNGIE syndrome) due to partial deficiency of cytochrome-c-oxidase. A new mitochondrial multisystem disorder. Acta Neuropathol (1987) 1.13
The role of microRNAs in arterial remodelling. Thromb Haemost (2012) 1.12
Micropuncture study of the action of angiotensin-II on tubular sodium and water reabsorption in the rat. Nephron (1969) 1.12
Biochemical and morphological investigations of 30 human insulinomas. Correlation between the tumour content of insulin and proinsulin-like components and the histological and ultrastructural appearance. Diabetologia (1973) 1.10
Analysis of mice carrying targeted mutations of the glucocorticoid receptor gene argues against an essential role of glucocorticoid signalling for generating adrenal chromaffin cells. Development (1999) 1.09
Glucagon-like peptide 1 (7-36 amide) secretion in response to luminal sucrose from the upper and lower gut. A study using alpha-glucosidase inhibition (acarbose). Scand J Gastroenterol (1995) 1.09
Serum lipoprotein Lp(a) concentrations are not influenced by an HMG CoA reductase inhibitor. Klin Wochenschr (1988) 1.09
Efficacy and safety of omeprazole in the long-term treatment of peptic ulcer and reflux oesophagitis resistant to ranitidine. Digestion (1990) 1.09
Reversal of impaired GIP and insulin secretion in patients with pancreatogenic steatorrhea following enzyme substitution. Diabetologia (1980) 1.08
Long-term omeprazole treatment in man: effects on gastric endocrine cell populations. Digestion (1988) 1.08
Genes, proteins, and neurotoxins involved in Parkinson's disease. Prog Neurobiol (2004) 1.07
[Chronic interstitial nephritis after treatment with 5-aminosalicylic acid]. Dtsch Med Wochenschr (1989) 1.07
Morphological and functional changes of pancreatic B cells in cyclosporin A-treated rats. Diabetologia (1984) 1.07
Somatostatin and insulin release from isolated rat pancreatic islets stimulated by glucose. FEBS Lett (1976) 1.07
Intracoronary infusion of autologous bone marrow cells and left ventricular function after acute myocardial infarction: a meta-analysis. J Cell Mol Med (2006) 1.07
Inhibition of gastric secretion by calcitonin in man. Horm Metab Res (1971) 1.06
Gastric inhibitory polypeptide (GIP), gastrin and insulin: response to test meal in coeliac disease and after duodeno-pancreatectomy. Diabetologia (1976) 1.05
Somatostatin and the stomach: exocrine and endocrine aspects. Metabolism (1978) 1.04
[Calcitonin-induced inhibition of exocrine pancreatic secretion in man]. Dtsch Med Wochenschr (1971) 1.04
GDF-15/MIC-1 a novel member of the TGF-beta superfamily. J Neural Transm Suppl (2000) 1.03
Contractile activity of human skeletal muscle cells prevents insulin resistance by inhibiting pro-inflammatory signalling pathways. Diabetologia (2012) 1.02
Analysis of the inhibitory effect of biguanides on glucose absorption: inhibition of active sugar transport. Diabetologia (1971) 1.02
Mechanism of insulin resistance in CCl4-induced cirrhosis of rats. Gastroenterology (1992) 1.02
[Inhibition by somatostatin of pancreatic juice and enzyme secretion and gallbladder contraction in man induced by secretin and cholecystokinin-pancreozymin administration (author's transl)]. Dtsch Med Wochenschr (1975) 1.01
The possible role of phospholipase A in the pathogenesis of acute pancreatitis. Scand J Gastroenterol (1969) 1.01
Association of ethylene-oxide-induced IgE antibodies with symptoms in dialysis patients. Lancet (1986) 1.00
The effect of indomethacin on plasma renin activity in man under normal conditions and after stimulation of the renin angiotensin system. Prostaglandins (1975) 1.00
Adaptation of the pancreas during treatment with enzyme inhibitors in rats and man. Scand J Gastroenterol Suppl (1985) 0.98
Gastric inhibitory polypeptide (GIP) and insulin in obesity: increased response to stimulation and defective feedback control of serum levels. Diabetologia (1978) 0.98
Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide. Am J Physiol (1991) 0.98
Antral gastrin-producing G-cells and somatostatin-producing D-cells in different states of gastric acid secretion. Gut (1982) 0.97
Binding of antibiotics by dialysis membranes and its clinical relevance. Proc Eur Dial Transplant Assoc (1977) 0.97
Exocrine pancreatic function in insulin-dependent diabetes mellitus. Digestion (1982) 0.97
[Hypoglycemia factitia. A differential diagnostic significant form of hyperinsulinism]. Dtsch Med Wochenschr (1969) 0.97
Comparison of low molecular weight heparin to standard heparin in hemodialysis/hemofiltration. Kidney Int (1988) 0.97
Effect of short- and long-term feeding of omeprazole on rat gastric endocrine cells. Digestion (1986) 0.96
Role of cholecystokinin in the negative feedback control of pancreatic enzyme secretion in conscious rats. Gastroenterology (1987) 0.96
Hepatocellular fibrinogen storage in familial hypofibrinogenemia. Virchows Arch B Cell Pathol Incl Mol Pathol (1981) 0.96
MicroRNAs in arterial remodelling, inflammation and atherosclerosis. Curr Drug Targets (2010) 0.96
Function of juxtamedullary nephrons in normotensive and chronically hypertensive rats. Pflugers Arch (1969) 0.96
Therapeutic potential of hemofiltration. Clin Nephrol (1979) 0.96
Increased ammonia production during forearm ischemic work test in McArdle's disease. Klin Wochenschr (1981) 0.96
Release of gastric inhibitory polypeptide (GIP) by intraduodenal acidification in rats and humans and abolishment of the incretin effect of acid by GIP-antiserum in rats. Gastroenterology (1979) 0.95
A small molecule CXCR4 antagonist inhibits neointima formation and smooth muscle progenitor cell mobilization after arterial injury. J Thromb Haemost (2008) 0.95
[A chronic destructive non-suppurative cholangitis-like disease picture with antinuclear antibodies (immunocholangitis)]. Dtsch Med Wochenschr (1987) 0.95
Camostate (FOY-305) improves the therapeutic effect of peritoneal lavage on taurocholate induced pancreatitis. Gut (1990) 0.94
The morphological substrate of the inhibition of insulin secretion by diazoxide. Horm Metab Res (1969) 0.94
Continuous arteriovenous haemofiltration. A new kidney replacement therapy. Proc Eur Dial Transplant Assoc (1981) 0.94
[Epidemiology of chronic hepatitis C in Germany--an analysis of 10,326 patients in hepatitis centres and outpatient units]. Z Gastroenterol (2008) 0.93
Circulating tachykinins (substance P, neurokinin A, neuropeptide K) and the carcinoid flush. Scand J Gastroenterol (1987) 0.93
Ampicillin levels in the serum and urine of patients with impaired renal function. Ger Med Mon (1966) 0.93
Gastrointestinal somatostatin: extraction and radioimmunoassay in different species. Gut (1978) 0.93
Omeprazole in the long-term management of patients with acid-related diseases resistant to ranitidine. Scand J Gastroenterol Suppl (1989) 0.93
Somatostatin therapy of acute experimental pancreatitis. Gut (1977) 0.93
Safety and potency aspects in the preparation of an experimental HBsAg vaccine. Dev Biol Stand (1983) 0.93
Etiology and incidence of acute pancreatitis: a 20-year study in a single institution. Digestion (1989) 0.92
Increase of intestinal brush border hydrolases in mucosa of streptozotocin-diabetic rats. Diabetologia (1972) 0.91
The effect of experimental cholestasis on the negative feedback regulation of cholesterol synthesis in rat liver. Scand J Gastroenterol (1970) 0.91
Effect of exogenous or endogenous gastric inhibitory polypeptide (GIP) on plasma triglyceride responses in rats. Horm Metab Res (1991) 0.91
Serotonin release into blood after food and pentagastrin. Studies in healthy subjects and in patients with metastatic carcinoid tumors. Gastroenterology (1986) 0.91
Different response of gastric inhibitory polypeptide to glucose and fat from duodenum and jejunum. Scand J Gastroenterol (1984) 0.90
Histochemistry, ultrastructure and hormone content of human insulinomas. Horm Metab Res (1976) 0.90